We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TYRES:OMXHEXNokian Renkaat Oyj Analysis

Data as of 2026-03-12 - not real-time

€9.34

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at €9.34, just above the identified support of €9.30, with the 20‑day SMA (≈10.44) sitting slightly below the 50‑day SMA (≈10.63), signaling a modest downtrend. RSI at 31.5 points to oversold conditions, while the MACD histogram is negative and the signal line is bearish, suggesting further downside pressure in the short run. Volume is increasing and the 30‑day volatility is high at roughly 37%, but the computed beta of 0.20 indicates limited sensitivity to broader market moves.
On the fundamentals side, the forward P/E of about 12 and a price‑to‑book of 1.1 place the valuation in a fair range, complemented by a 2.59% dividend yield with a modest 13.75% payout ratio, implying decent sustainability. However, a high debt‑to‑equity ratio near 70% and modest free cash flow raise concerns, even as the company rolls out a new climate transition plan and strategic targets that underpin a modest upside of ~5% per analyst consensus. The overall picture suggests a potential buying opportunity on the dip, a hold for the medium term, and close monitoring of leverage and cash generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support
  • Oversold RSI indicating potential rebound
  • Bearish MACD suggesting caution

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings growth and reasonable valuation
  • Attractive dividend yield with low payout
  • Modest upside target and improving volume

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong brand in winter tire niche and climate strategy
  • High debt levels requiring monitoring
  • Sustainable dividend supporting shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin-1.09%
P/E Ratio12.0
ROE-1.23%
ROA0.93%
Debt/Equity69.65
P/B Ratio1.1
Op. Cash Flow€146.2M
Free Cash Flow€12.3M

Technical Analysis

TrendNeutral
RSI31.5
Support€9.30
Resistance€11.48
MA 20€10.44
MA 50€10.63
MA 200€8.45
MACDBearish
VolumeIncreasing
Fear & Greed Index73.46

Valuation

Target Price€9.84
Upside/Downside5.38%
GradeFair
TypeBlend
Dividend Yield2.59%

Risk Assessment

Beta0.20
Volatility36.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.